Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors. (2022)
Attributed to:
MICA: Optimising combination strategies for chimeric antigen receptor therapy in multiple myeloma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.17864
PubMed Identifier: 34632575
Publication URI: http://europepmc.org/abstract/MED/34632575
Type: Journal Article/Review
Volume: 196
Parent Publication: British journal of haematology
Issue: 3
ISSN: 0007-1048